Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for chronic prostatitis/chronic pelvic pain syndrome
IRCT20260618069860N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of escitalopram in chronic prostatitis (CP), sponsored by Hamadan University of Medical Sciences. Started Jun 2026; status: completed.
02
Drugs
escitalopram
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on IRCT20260618069860N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260618069860N1.